Synaptic, transcriptional and chromatin genes disrupted in autism S De Rubeis, X He, AP Goldberg, CS Poultney, K Samocha, ... Nature 515 (7526), 209-215, 2014 | 2730 | 2014 |
Patterns and rates of exonic de novo mutations in autism spectrum disorders BM Neale, Y Kou, L Liu, A Ma’Ayan, KE Samocha, A Sabo, CF Lin, ... Nature 485 (7397), 242-245, 2012 | 2022 | 2012 |
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ... Nature genetics 43 (7), 699-705, 2011 | 622 | 2011 |
Identification of required host factors for SARS-CoV-2 infection in human cells Z Daniloski, TX Jordan, HH Wessels, DA Hoagland, S Kasela, M Legut, ... Cell 184 (1), 92-105. e16, 2021 | 517 | 2021 |
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy N Kouri, OA Ross, B Dombroski, CS Younkin, A Soto-Ortolaza, M Baker, ... Nature communications 6 (1), 1-7, 2015 | 207 | 2015 |
Massively parallel discovery of human-specific substitutions that alter enhancer activity S Uebbing, J Gockley, SK Reilly, AA Kocher, E Geller, N Gandotra, ... Proceedings of the National Academy of Sciences 118 (2), e2007049118, 2021 | 76 | 2021 |
Antisense-mediated exon skipping decreases tau protein expression: a potential therapy for tauopathies R Sud, ET Geller, GD Schellenberg Molecular Therapy-Nucleic Acids 3, 2014 | 76 | 2014 |
Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens N Liscovitch-Brauer, A Montalbano, J Deng, A Méndez-Mancilla, ... Nature biotechnology 39 (10), 1270-1277, 2021 | 57 | 2021 |
A statistical framework for mapping risk genes from de novo mutations in whole-genome-sequencing studies Y Liu, Y Liang, AE Cicek, Z Li, J Li, RA Muhle, M Krenzer, Y Mei, Y Wang, ... The American Journal of Human Genetics 102 (6), 1031-1047, 2018 | 30 | 2018 |
Massively parallel discovery of human-specific substitutions that alter neurodevelopmental enhancer activity S Uebbing, J Gockley, SK Reilly, AA Kocher, E Geller, N Gandotra, ... Biorxiv, 865519, 2019 | 9 | 2019 |
Scalable pooled CRISPR screens with single-cell chromatin accessibility profiling N Liscovitch-Brauer, A Montalbano, J Deng, A Méndez-Mancilla, ... BioRxiv, 2020.11. 20.390971, 2020 | 8 | 2020 |
Massively parallel disruption of enhancers active during human corticogenesis E Geller, J Gockley, D Emera, S Uebbing, J Cotney, JP Noonan bioRxiv, 852673, 2019 | 4 | 2019 |
Synaptic, transcriptional and chromatin genes disrupted in autism. K Samocha, AE Cicek, L Liu, L Klei, J Kosmicki, M Biscaldi, JM Brownfeld, ... Nature 515 (7526), 2014 | 4 | 2014 |
DRAW+ SneakPeek: Analysis workflow and quality metric management for DNA-seq experiments CF Lin, O Valladares, DM Childress, E Klevak, ET Geller, YC Hwang, ... Bioinformatics 29 (19), 2498-2500, 2013 | 4 | 2013 |
Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected families Y Liu, E Cicek, Y Liang, J Li, R Muhle, N Knoblauch, M Krenzer, Y Mei, ... bioRxiv, 077578, 2016 | 1 | 2016 |
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. NM Melhem, DW Dickson, P Sleiman, LS Wang, L Klei, R Rademakers, ... 1546-1718, 2011 | 1 | 2011 |
Massively parallel disruption of enhancers active in human neural stem cells E Geller, MA Noble, M Morales, J Gockley, D Emera, S Uebbing, ... Cell Reports 43 (2), 2024 | | 2024 |
Massively Parallel Genetic Disruption of Enhancers Active during Human Corticogenesis ETB Geller Yale University, 2019 | | 2019 |
P4‐440: Decline in tau levels from antisense oligo treatment: A potential curative mechanism for Alzheimer's disease R Sud, E Geller, G Schellenberg Alzheimer's & Dementia 7, e65-e65, 2011 | | 2011 |
Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected 2 families 3 MK Knoblauch, Y Mei, Y Wang, Y Jiang, E Geller, Z Li, I Ionita-Laza11, ... | | |